Aug. 29 at 12:31 AM
$CAPR You guys want to have some fun? Enter the following into ChatGPT: I want to estimate potential price per share as of December 31, 2026, if the FDA approves Deramiocel by November 22, 2026. These are the assumptions I would like for you to take into account: (1) There are some 15,000 boys who have DMD in the United States, but Capricor can only treat up to 2,500 in the first year, starting with 500 at first. (2) The treatments cost 300,000.00 each - one treatment per quarter. (3) Company expense are 10% of gross income. (4) Capricor will NOT have to pay 50% of its gross earnings to NS. (5) Capricor has 65,000,000 shares outstanding, fully diluted. (6) Capricor had
$238,000,00 in cash on hand at 6/30/2026, and (7) Capricor will get a voucher payment of
$200,000,000 upon FDA approval. Can you help?
